SEARCH

SEARCH BY CITATION

References

  • 1
    von Economo C (1930) Sleep as a problem of localization. J Nerv Ment Dis 71, 249259.
  • 2
    Gautvik KM, de Lecea L, Gautvik VT, Danielson PE, Tranque P, Dopazo A, Bloom FE & Sutcliffe JG (1996) Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 93, 87338738.
  • 3
    de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS II et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95, 322327.
  • 4
    Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573585.
  • 5
    Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE, Ollmann MM, Barsh GS et al. (1998) Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402, 442459.
  • 6
    Broberger C, de Lecea L, Sutcliffe JG & Hökfelt T (1998) Hypocretin/orexin- and melanin-concentrating hormone expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to neuropeptide Y innervation. J Comp Neurol 402, 460474.
  • 7
    Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG & Kilduff TS (1998) Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems. J Neurosci 18, 999610015.
  • 8
    Steininger TL, Kilduff TS, Behan M, Benca RM & Landry CF (2004) Comparison of hypocretin/orexin and melanin-concentrating hormone neurons and axonal projections in the embryonic and postnatal rat brain. J Chem Neuroanat 27, 165181.
  • 9
    Porkka-Heiskanen T, Alanko L, Kalinchuk A, Heiskanen S & Stenberg D (2004) The effect of age on prepro-orexin gene expression and contents of orexin A and B in the rat brain. Neurobiol Aging 25, 231238.
  • 10
    Moore RY, Abrahamson EA & van den Pol A (2001) The hypocretin neuron system: an arousal system in the human brain. Arch Ital Biol 139, 195205.
  • 11
    Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R & Maratos-Flier E (1996) A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243247.
  • 12
    Hakansson M, de Lecea L, Sutcliffe JG, Yanagisawa M & Meister B (1999) Leptin receptor- and STAT3-immunoreactivities in Hypocretin/Orexin neurones of the lateral hypothalamus. J Neuroendocrinol 11, 653663.
  • 13
    Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, Willie JT, Beuckmann CT, Chemelli RM, Sakurai T, Yanagisawa M, Saper CB & Scammell TE (2001) Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21, RC168.
  • 14
    Bayer L, Mairet-Coello G, Risold PY & Griffond B (2002) Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin-concentrating hormone neurons. Regul Pept 104, 3339.
  • 15
    Abrahamson EE, Leak RK & Moore RY (2001) The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport 12, 435440.
  • 16
    Rosin DL, Weston MC, Sevigny CP, Stornetta RL & Guyenet PG (2003) Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 465, 593603.
  • 17
    Li Y, Gao XB, Sakurai T & van den Pol AN (2002) Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36, 11691181.
  • 18
    Collin M, Backberg M, Ovesjo ML, Fisone G, Edwards RH, Fujiyama F & Meister B (2003) Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. Eur J Neurosci 18, 12651278.
  • 19
    Torrealba F, Yanagisawa M & Saper CB (2003) Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119, 10331044.
  • 20
    Moragues N, Ciofi P, Lafon P, Tramu G & Garret M (2003) GABAA receptor epsilon subunit expression in identified peptidergic neurons of the rat hypothalamus. Brain Res 967, 285289.
  • 21
    Muraki Y, Yamanaka A, Tsujino N, Kilduff TS, Goto K & Sakurai T (2004) Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 24, 71597166.
  • 22
    Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ & DiLeone RJ (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23, 31063111.
  • 23
    Campbell RE, Smith MS, Allen SE, Grayson BE, Ffrench-Mullen JM & Grove KL (2003) Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J Neurosci 23, 14871497.
  • 24
    Thakkar MM, Winston S & McCarley RW (2002) Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Res 944, 190194.
  • 25
    Nilaweera KN, Barrett P, Mercer JG & Morgan PJ (2003) Precursor-protein convertase 1 gene expression in the mouse hypothalamus: differential regulation by ob gene mutation, energy deficit and administration of leptin, and coexpression with prepro-orexin. Neuroscience 119, 713720.
  • 26
    Reti IM, Reddy R, Worley PF & Baraban JM (2002) Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons. J Neurochem 82, 15611565.
  • 27
    Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS & van Den Pol AN (1999) Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415, 145159.
  • 28
    Horvath TL, Diano S & van den Pol AN (1999) Synaptic interaction between hypocretin (Orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19, 10721087.
  • 29
    van den Pol AN, Acuna-Goycolea C, Clark KR & Ghosh PK (2004) Physiological Properties of Hypothalamic MCH Neurons Identified with Selective Expression of Reporter Gene after Recombinant Virus Infection. Neuron 42, 635652.
  • 30
    Guan JL, Uehara K, Lu S, Wang QP, Funahashi H, Sakurai T, Yanagizawa M & Shioda S (2002) Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation. Int J Obes Relat Metab Disord 26, 15231532.
  • 31
    van den Pol AN (1999) Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 19, 31713182.
  • 32
    Espana RA, Reis KM, Valentino RJ & Berridge CW (2005) Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J Comp Neurol 481, 160178.
  • 33
    Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL & de Lecea L (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24, 1143911448.
  • 34
    Upton , N (2005) In vivo pharmacology of orexin (hypocretin) receptors. In Hypocretins: Integrators of Physiological Functions (de LeceaL & SutcliffeJG, eds). pp. 205220. Springer, New York.
  • 35
    McCormick DA & Bal T (1997) Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 20, 185215.
  • 36
    Steriade M, McCormick DA & Sejnowski TJ (1993) Thalamocortical oscillations in the sleeping and aroused brain. Science 262, 679685.
  • 37
    Jones , B (1994) Basic mechanisms of sleep-wake states. In Principles and Practice of Sleep Medicine (KrygerM, RothT, & DementWC, eds). pp. 145162. W.B. Saunders Co, Philadelphia.
  • 38
    Saper CB, Chou TC & Scammell TE (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24, 726731.
  • 39
    Sinton CM & McCarley RW (2004) Neurophysiological mechanisms of sleep and wakefulness: a question of balance. Semin Neurol 24, 211223.
  • 40
    Siegel JM (2004) The neurotransmitters of sleep. J Clin Psychiatry 65 (Suppl. 16), 47.
  • 41
    Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S et al. (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68, 686699.
  • 42
    Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S & Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365376.
  • 43
    Hungs M, Fan J, Lin L, Lin X, Maki RA & Mignot E (2001) Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res 11, 531539.
  • 44
    John J, Wu MF, Maidment NT, Lam HA, Boehmer LN, Patton M & Siegel JM (2004) Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers. J Physiol 560, 587592.
  • 45
    Dauvilliers Y, Carlander B, Rivier F, Touchon J & Tafti M (2004) Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 56, 905908.
  • 46
    Boehmer LN, Wu MF, John J & Siegel JM (2004) Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity. Exp Neurol 188, 292299.
  • 47
    Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437451.
  • 48
    Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T & Scammell TE (2004) Behavioral state instability in orexin knock-out mice. J Neurosci 24, 62916300.
  • 49
    Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA et al. (2003) Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38, 715730.
  • 50
    Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, Lappi DA & Shiromani PJ (2001) Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 21, 72737283.
  • 51
    Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M & Sakurai T (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345354.
  • 52
    Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T & Yanagisawa M (2004) Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 24, 44694477.
  • 53
    Nishino S, Ripley B, Overeem S, Lammers GJ & Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy [letter]. Lancet 355, 3940.
  • 54
    Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, Di Monte D, Dohi K, Melberg A, Lammers GJ et al. (2001) CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57, 22532258.
  • 55
    Yoshikawa S, Suzuki S, Kanbayashi T, Nishino S & Tamai H (2004) Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis. Pediatr Neurol 31, 367370.
  • 56
    Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E & Nishino S (2005) Hypocretin deficiency in Prader–Willi syndrome. Eur J Neurol 12, 7072.
  • 57
    Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6, 991997.
  • 58
    Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M & Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469474.
  • 59
    Thompson MD, Comings DE, Abu-Ghazalah R, Jereseh Y, Lin L, Wade J, Sakurai T, Tokita S, Yoshida T, Tanaka H, Yanagisawa M, Burnham WM & Moldofsky H (2004) Variants of the orexin2/hcrt2 receptor gene identified in patients with excessive daytime sleepiness and patients with Tourette's syndrome comorbidity. Am J Med Genet 129B, 6975.
  • 60
    Lin , L & Mignot E (2004) HLA and narcolepsy: present status and relationship with familial history and hypocretin deficiency. In Narcolepsy and Hypersomnia, Volume in Press (BassettiC, BilliardM & MignotE, eds). pp. 148196. Marcel Dekker, New York.
  • 61
    Katsuki H & Akaike A (2004) Excitotoxic degeneration of hypothalamic orexin neurons in slice culture. Neurobiol Dis 15, 6169.
  • 62
    Petersen A, Gil J, Maat-Schieman ML, Bjorkqvist M, Tanila H, Araujo IM, Smith R, Popovic N, Wierup N, Norlen P et al. (2005) Orexin loss in Huntington's disease. Hum Mol Genet 14, 3947.
  • 63
    Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW & Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493506.
  • 64
    Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E & Nishino S (2001) Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur J Neurosci 14, 10751081.
  • 65
    Salomon RM, Ripley B, Kennedy JS, Johnson B, Schmidt D, Zeitzer JM, Nishino S & Mignot E (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54, 96104.
  • 66
    Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H & Nishino S (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59, 15531562.
  • 67
    Higuchi S, Usui A, Murasaki M, Matsushita S, Nishioka N, Yoshino A, Matsui T, Muraoka H, Ishizuka Y, Kanba S & Sakurai T (2002) Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett 318, 6164.
  • 68
    Sakurai S, Nishijima T, Takahashi S, Yamauchi K, Arihara Z & Takahashi K (2004) Clinical significance of daytime plasma orexin-A-like immunoreactivity concentrations in patients with obstructive sleep apnea hypopnea syndrome. Respiration 71, 380384.
  • 69
    Busquets X, Barbe F, Barcelo A, de la Pena M, Sigritz N, Mayoralas LR, Ladaria A & Agusti A (2004) Decreased plasma levels of orexin-A in sleep apnea. Respiration 71, 575579.
  • 70
    Overeem S, Mignot E, van Dijk JG & Lammers GJ (2001) Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 18, 78105.
  • 71
    Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J & Lammers GJ (2004) Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 62, 138140.
  • 72
    Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P & Rosenfeld MR (2004) Clinical analysis of anti-Ma2-associated encephalitis. Brain 127, 18311844.
  • 73
    Castillo PR, Mignot E, Woodruff BK & Boeve BF (2004) Undetectable CSF hypocretin-1 in ‘Hashimoto's encephalopathy' associated with coma. Neurology 62, 1909.
  • 74
    Gledhill RF, Bartel PR, Yoshida Y, Nishino S & Scammell TE (2004) Narcolepsy caused by acute disseminated encephalomyelitis. Arch Neurol 61, 758760.
  • 75
    Smith AJ, Jackson MW, Neufing P, McEvoy RD & Gordon TP (2004) A functional autoantibody in narcolepsy. Lancet 364, 21222124.
  • 76
    Fujiki N, Yoshida Y, Ripley B, Mignot E & Nishino S (2003) Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. Sleep 26, 953959.
  • 77
    Fujiki N, Yoshida Y, Ripley B, Mignot E & Nishino S (2001) Effect of systemic and central administration of hypocretin 1 in narcoleptic (hcrt r2 mutated) and control dogs. Sleep 24, A96.
  • 78
    Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T & Yanagisawa M (2004) Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA 101, 46494654.
  • 79
    Pace-Schott EF & Hobson JA (2002) The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3, 591605.
  • 80
    Xi M, Morales FR & Chase MH (2001) Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 901, 259264.
  • 81
    Espana RA, Baldo BA, Kelley AE & Berridge CW (2001) Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106, 699715.
  • 82
    Satoh S, Matsumura H, Fujioka A, Nakajima T, Kanbayashi T, Nishino S, Shigeyoshi Y & Yoneda H (2004) FOS expression in orexin neurons following muscimol perfusion of preoptic area. Neuroreport 15, 11271131.
  • 83
    Thakkar MM, Ramesh V, Strecker RE & McCarley RW (2001) Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 139, 313328.
  • 84
    Alam MN, Gong H, Alam T, Jaganath R, McGinty D & Szymusiak R (2002) Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol 538, 619631.
  • 85
    Mileykovskiy BY, Kiyashchenko LI & Siegel JM (2005) Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46, 787798.
  • 86
    Lee MG, Hassani OK & Jones BE (2005) Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25, 67166720.
  • 87
    Alam MN, Kumar S, Bashir T, Suntsova N, Methippara MM, Szymusiak R & McGinty D (2004) Evidence for GABA mediated control of hypocretin- but not MCH-immunoreactive neurons during sleep in rats. J Physiol 5632, 569582.
  • 88
    Bourgin P, Huitrón-Reséndiz S, Spier A, Fabre V, Morte B, Criado J, Sutcliffe J, Henriksen S & de Lecea L (2000) Hypocretin-1 modulates REM sleep through activation of locus coeruleus neurons. J Neurosci 20, 77607765.
  • 89
    Aston-Jones G, Chen S, Zhu Y & Oshinsky ML (2001) A neural circuit for circadian regulation of arousal. Nat Neurosci 4, 732738.
  • 90
    Steriade M & Llinas RR (1988) The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 68, 649742.
  • 91
    Jones BE (1991) The role of noradrenergic locus coeruleus neurons and neighboring cholinergic neurons of the pontomesencephalic tegmentum in sleep-wake states. Prog Brain Res 88, 533543.
  • 92
    Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH & Guan XM (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438, 7175.
  • 93
    Greco MA & Shiromani PJ (2001) Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res Mol Brain Res 88, 176182.
  • 94
    Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M & Elmquist JK (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435, 625.
  • 95
    Burlet S, Tyler CJ & Leonard CS (2002) Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22, 28622872.
  • 96
    Takahashi K, Koyama Y, Kayama Y & Yamamoto M (2002) Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin Neurosci 56, 335336.
  • 97
    Brown RE, Sergeeva O, Eriksson KS & Haas HL (2001) Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40, 457459.
  • 98
    Panula P, Yang HY & Costa E (1984) Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81, 25722576.
  • 99
    Haas H & Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4, 121130.
  • 100
    Panula P, Pirvola U, Auvinen S & Airaksinen MS (1989) Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28, 585610.
  • 101
    Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T & Lin JS (2002) Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22, 76957711.
  • 102
    Bayer L, Eggermann E, Serafin M, Saint-Mleux B, Machard D, Jones B & Muhlethaler M (2001) Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 14, 15711575.
  • 103
    Eriksson KS, Sergeeva O, Brown RE & Haas HL (2001) Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21, 92739279.
  • 104
    Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JIJ, Wang QP, Tominaga M, Goto K, Shioda S & Sakurai T (2002) Orexins Activate Histaminergic Neurons via the Orexin 2 Receptor. Biochem Biophys Res Commun 290, 12371245.
  • 105
    Lambe EK & Aghajanian GK (2003) Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40, 139150.
  • 106
    Bayer L, Serafin M, Eggermann E, Saint-Mleux B, Machard D, Jones BE & Muhlethaler M (2004) Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 24, 67606764.
  • 107
    Hirota K, Kushikata T, Kudo M, Kudo T, Lambert DG & Matsuki A (2001) Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol 134, 14611466.
  • 108
    Selbach O, Doreulee N, Bohla C, Eriksson KS, Sergeeva OA, Poelchen W, Brown RE & Haas HL (2004) Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience 127, 519528.
  • 109
    Acuña-Goycolea C, Li Y & van den Pol AN (2004) Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons. J Neurosci 24, 30133022.
  • 110
    Fu LY, Acuña-Goycolea C & van den Pol AN (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24, 87418751.
  • 111
    Acuña-Goycolea C & van den Pol A (2004) Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 24, 81418152.
  • 112
    Li Y & van den Pol AN (2005) Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 25, 173183.
  • 113
    Tsujino N, Yamanaka A, Ichiki K, Muraki Y, Kilduff TS, Yagami K, Takahashi S, Goto K & Sakurai T (2005) Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J Neurosci 25, 74597469.
  • 114
    Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L & Civelli O (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43, 487497.
  • 115
    Pedrazzoli M, D'Almeida V, Martins PJ, Machado RB, Ling L, Nishino S, Tufik S & Mignot E (2004) Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Res 995, 16.
  • 116
    Deboer T, Overeem S, Visser NA, Duindam H, Frolich M, Lammers GJ & Meijer JH (2004) Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 129, 727732.
  • 117
    Zhang S, Zeitzer JM, Yoshida Y, Wisor JP, Nishino S, Edgar DM & Mignot E (2004) Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep 27, 619627.
  • 118
    Reyes TM, Walker JR, DeCino C, Hogenesch JB & Sawchenko PE (2003) Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 23, 56075616.